Monoclonal antibodies attach to the spike protein of the SARS-CoV-2 virus (the virus that causes COVID-19). Your kidneys or liver do not digest this drug, so it should not interfere with other medications you are on. We will give you one dose of this treatment through an IV in an outpatient setting. How Does a Monoclonal Antibody Infusion Work? You are receiving high doses of steroids or other drugs to suppress your immune system.Have a compromised immune system, such as, patients with cancer and those who have undergone transplantation.Have underlying conditions, such as diabetes or chronic heart disease.We are giving these treatments on an outpatient basis if you are already in the hospital, you cannot receive this outpatient infusion. Get the infusion within 10 days of when your symptoms started.Have a high risk of getting sicker and going to the hospital.Have mild or moderate COVID-19 symptoms.To get this treatment, you must meet these requirements: It is important to get tested as early as possible, within 10 days of showing symptoms.We give these treatments to help keep you out of the hospitals and make the disease less severe.These are experimental drugs that have benefited certain patients in a drug trial.UT Medical Center is now treating patients with COVID-19 with monoclonal antibody infusions.General Information About Monoclonal Antibody Infusions If you are a health care provider and would like to refer a patient, visit patient referrals. As a result, you need an appointment with UT Medical Center to receive the drug. Have an appointment - This drug is an infusion, which means it is given via IV directly into your bloodstream.Be referred by a physician - Once you see a health care provider, he or she must refer you to UT Medical Center.Be screened - Your doctor or health care provider must see you first to make make sure you meet the requirements for getting this drug (see вЂњWho Can Get the Treatment?вЂќ below).Know Before You GoД«efore you can receive a monoclonal antibody infusion, you must: Those drugs given in the infusions are: bamlanivimab-etesevimab and casirivimab-imdevimab. The Food and Drug Administration gave health care providers permission to use monoclonal antibody infusions to treat patients who have tested positive for COVID-19.

Monal clonal antibody